ATE308890T1 - Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit - Google Patents

Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Info

Publication number
ATE308890T1
ATE308890T1 AT02739223T AT02739223T ATE308890T1 AT E308890 T1 ATE308890 T1 AT E308890T1 AT 02739223 T AT02739223 T AT 02739223T AT 02739223 T AT02739223 T AT 02739223T AT E308890 T1 ATE308890 T1 AT E308890T1
Authority
AT
Austria
Prior art keywords
shilajit
composition
purified
native
producing
Prior art date
Application number
AT02739223T
Other languages
English (en)
Inventor
Shibnath Ghosal
Original Assignee
Natreon Inc
Indian Herbs Res & Supply Comp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natreon Inc, Indian Herbs Res & Supply Comp filed Critical Natreon Inc
Application granted granted Critical
Publication of ATE308890T1 publication Critical patent/ATE308890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
AT02739223T 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit ATE308890T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/860,890 US6440436B1 (en) 2001-05-18 2001-05-18 Process for preparing purified shilajit composition from native shilajit
PCT/US2002/014259 WO2002094984A2 (en) 2001-05-18 2002-05-03 Process for preparing purified shilajit composition from native shilajit

Publications (1)

Publication Number Publication Date
ATE308890T1 true ATE308890T1 (de) 2005-11-15

Family

ID=25334290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02739223T ATE308890T1 (de) 2001-05-18 2002-05-03 Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit

Country Status (7)

Country Link
US (2) US6440436B1 (de)
EP (1) EP1387614B1 (de)
AT (1) ATE308890T1 (de)
AU (1) AU2002311886A1 (de)
DE (1) DE60207234T2 (de)
ES (1) ES2252467T3 (de)
WO (1) WO2002094984A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit
US6558712B1 (en) * 2001-09-21 2003-05-06 Natreon Inc. Delivery system for pharmaceutical, nutritional and cosmetic ingredients
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
US20050233942A1 (en) * 2004-04-14 2005-10-20 Shibnath Ghosal Oxygenated dibenzo-alpha-pyrone chromoproteins
WO2005099739A1 (en) * 2004-04-14 2005-10-27 Natreon, Inc. Oxygenated dibenzo-alpha-pyrone chromoproteins
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
US7250181B2 (en) * 2005-01-19 2007-07-31 Natreon, Inc. Polyherbal compositions and methods for treating viral infections
CN100408653C (zh) * 2005-03-11 2008-08-06 吉林农业大学 土壤生物活化剂
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
AU2007219981B2 (en) 2006-02-28 2013-11-07 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
KR100801057B1 (ko) * 2006-07-18 2008-02-04 삼성전자주식회사 컬러 보정 블럭을 구비하는 ｃｍｏｓ 이미지 센서 및 그이미지 센싱 방법
US8894993B2 (en) * 2006-08-04 2014-11-25 Natreon Inc. Mitochondria-targeted antioxidants
CL2009001956A1 (es) * 2009-10-09 2010-06-04 Neuroinnovation Spa Composicion nutracéutica que comprende extracto de shilajit (250-500 mg), acido folico (200-500 ug), vitamina b6(20-40 ug), vitamina b12 (4-8 ug) y excipientes aceptables; metodo de fabricacion; y su uso para prevenir o tratar la enfermedad de alzheimer.
EP2654461B1 (de) 2010-12-23 2018-04-11 Amazentis SA Zusammensetzungen und verfahren zur behandlung von stoffwechselstörungen
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
US20120213756A1 (en) * 2011-02-21 2012-08-23 Rosemary Petralia Nutraceutical beverage
CN105142632B (zh) 2012-06-27 2020-01-07 阿马曾提斯公司 通过投予尿石素或其前体增强自噬或增加寿命
AU2015243531A1 (en) * 2014-04-08 2016-11-17 Christopher VANDECAR Plant and animal extracts and related methods
US10183047B2 (en) 2014-05-21 2019-01-22 Natreon, Inc. Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
EP3960186A3 (de) 2014-10-02 2022-03-23 Natreon, Inc. Förderung der knochengesundheit und reparatur und behandlung von erkrankungen im zusammenhang mit kollagen und entsprechenden proteinen durch verwendung von shilajit
JP2017007951A (ja) * 2015-06-17 2017-01-12 公立大学法人岡山県立大学 ウロリチンを含有する光老化抑制剤
JP2017014154A (ja) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 ウロリチン類を含有するヒアルロン酸産生促進剤
JP6799767B2 (ja) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 ウロリチン類を含有するメラニン産生抑制剤
JP2017031108A (ja) * 2015-08-04 2017-02-09 公立大学法人岡山県立大学 ウロリチン類を含有する、抗しわ剤、コラーゲン産生促進剤、ｍｍｐ−１産生抑制剤、及びエラスターゼ活性阻害剤
US11292731B2 (en) 2017-02-02 2022-04-05 Christopher Vandecar Method and apparatus for treating contaminated fluid medium
EP4566601A3 (de) 2017-03-08 2025-09-03 Amazentis SA Verfahren zur verbesserung der mitophagie bei personen
US20180256471A1 (en) * 2017-03-08 2018-09-13 Amazentis Sa Skin Treatment Methods
KR101844849B1 (ko) 2017-07-27 2018-04-04 주식회사 제니버 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법
CA3104621C (en) * 2018-06-26 2022-02-08 Natreon, Inc. Improvement of blood microperfusion to skin by shilajit
CN109363956B (zh) * 2018-12-29 2022-05-13 广州市科能化妆品科研有限公司 喜来芝提取物的用途和美白水分露及其制备方法
EP3799854A1 (de) 2019-10-01 2021-04-07 Stefan Johannes Fellner Extrakt von organischen humifizierten materialien
WO2022040321A1 (en) * 2020-08-19 2022-02-24 Natreon, Inc. Protection against coronavirus infection by extracts and extract components
KR20240132587A (ko) 2023-02-27 2024-09-04 의료법인 명지의료재단 실라짓을 포함하는 알츠하이머성 치매 예방 및 치료용 조성물
GB202308224D0 (en) 2023-06-01 2023-07-19 Amazentis Sa Formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405613A (en) * 1991-12-11 1995-04-11 Creative Nutrition Canada Corp. Vitamin/mineral composition
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit

Also Published As

Publication number Publication date
DE60207234D1 (de) 2005-12-15
EP1387614A2 (de) 2004-02-11
WO2002094984A3 (en) 2003-03-06
WO2002094984A2 (en) 2002-11-28
DE60207234T2 (de) 2006-08-03
AU2002311886A1 (en) 2002-12-03
ES2252467T3 (es) 2006-05-16
US6869612B2 (en) 2005-03-22
EP1387614A4 (de) 2004-09-15
US6440436B1 (en) 2002-08-27
EP1387614B1 (de) 2005-11-09
US20030039662A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
DE60207234D1 (de) Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit
ATE517607T1 (de) Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
DE50111495D1 (de) Künstliche sauerstoffträger aus vernetztem modifizierten human- oder schweinehämoglobin, verfahren zu ihrer herstellung aus gereinigtem material, sowie deren verwendung
DE60042375D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutanal
DE60227951D1 (de) Delta-4-desaturase-gene und ihre verwendung
WO2005035441A3 (en) Subtituted fullerene compositions and their use as antioxydants
ATE410162T1 (de) Verfahren zur herstellung einer fein selbstemulgierbaren pharmazeutischen zusammensetzung
ES2092266T3 (es) Composiciones para la nutricion ingeribles oralmente, que tienen apetibilidad mejorada.
DE69005247D1 (de) Orale Präparate gegen Zahnbeläge.
DE59207907D1 (de) Benzopyranone, verfahren zu ihrer herstellung und verwendung
DE60034919D1 (de) Kosmetische Zubereitung Ester hydroxylierter Fettsäuren enthaltend
ATE294137T1 (de) Verfahren zur herstellung von orthokieselsäure, sowie nach dem verfahren hergestellte kieselsäure und ihre verwendung
ATE290324T1 (de) Eine feuchtigkeit- und sauerstoff-stabile zusammensetzung und verfahren zur herstellung
DE50203302D1 (de) Verfahren zur herstellung von direkt tablettierbarem alpha-mannit
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
EP1018337A3 (de) Chlorhexidin-Formulierungen, neue Chlorhexidinsalze, sie enthaltende Lösungen und deren Verwendung
DE50106251D1 (de) Mittel und verfahren zu dauerhaften haarverformung auf basis von 2-mercaptopropionsäureamiden sowie verfahren zu deren herstellung
EP1222919A3 (de) Zusammensetzungen enthaltend Glykoproteinematrix und Wirkstoff und Verfahren zur Herstellung desselben
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
ATE326442T1 (de) Verfahren zur herstellung von essigsäure
DE60033414D1 (de) Allergievakzine sowie ihre Herstellung
DE60031315D1 (de) Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties